JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
There are no items in your shopping cart
Featured Products
Axon 3814
CAS [1357576-48-7]
MF C45H48ClF3N4O7S3MW 945.53
AZD4320 is a BH3 mimetic and highly potent dual Bcl-2/Bcl-XL inhibitor with binding affinity in low nanomolar range similar to ABT-263 (Axon 3821), but with a better therapeutic index (lower toxicities) and amenable to I. V. administration. It rapidly induces caspase-3 (CC3) cleavage and cell death in both Bcl-2-driven (SuDHL4, GI50 24 days) tumor regressions in a mouse RS4;11 acute lymphocytic leukemia xenograft model (20 mg/kg, i.v.).
KEYWORDS: AZD4320 | Supplier | BH3-mimetic inhibitor of BCL-2 protein | AZD-4320 | AZD 4320 | CT-A4320 | CAS [1357576-48-7] | Non Selective | Bcl | Inhibitor | Proteins
4-(4-((R)-(4'-Chlorobiphenyl-2-yl)(hydroxy)methyl)piperidin-1-yl)-N-(4-((R)-4-((2-hydroxyethyl)(methyl)amino)-1-(phenylthio)butan-2-ylamino)-3-(trifluoromethylsulfonyl)phenylsulfonyl)benzamide
[1357576-48-7]
The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.
Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!
* Required Fields